Although experimental evidence suggests that CDX2 is considered to be a potential tumor suppressor because it inhibits cell growth, migration, and dissemination of CRC cells (21), CDX2 expression is observed in over 90% of colorectal liver metastases and it is concordant between primary CRC and the corresponding liver metastases (22). This evidence concerns the gene CDX2 and colorectal carcinoma.